Saturday, December 20, 2014   

France busts record 2.4m doses of dodgy China drugs
(04-10 18:56)

French customs have confiscated millions of counterfeit drugs from China in what they described as the biggest seizure in the European Union.
A total of 2.4 million doses of drugs for ailments including diarrhea, headaches and erectile dysfunction were seized at the end of February in the port of Le Havre in boxes labelled as containing Chinese tea, customs officials said today.
“Some of the drugs contain no active ingredient, which constitutes outright cheating of consumers,'' a statement from the customs executive said.
“Others have different levels of the active ingredient compared to the authentic drug which means they could represent a serious health risk for patients taking them.''
According to French customs, the previous record seizure in the EU was for 1.2 million doses of counterfeit aspirin, also made at Le Havre in Normandy, in May 2013.—AFP
   
Other World breaking news:
Malaysia charges Australian mum with drug trafficking (12-19 13:10)
Up to 11 dead in Japan snow storms: reports (12-19 12:47)
Japanese scientist resigns over stem cell scandal (12-19 12:36)
SKorea far-left party dissolved for 'backing NKorea' (12-19 11:20)
11th Sierra Leonean doctor dies from Ebola (12-18 18:30)
SKorean group cancels plans for border tree (12-18 17:57)
Merkel says Russia sanctions remain 'unavoidable' (12-18 17:55)
Airbags could have expiry date: Japan auto industry chief (12-18 17:49)
Russian economy to rebound in two years at latest: Putin (12-18 17:37)
Japan lab cannot repeat ground-breaking cell finding (12-18 15:04)

More breaking news >>

© 2014 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2014, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.